Breast Cancer Trial, Recruiting NCT07070778 Sponsor: Hacettepe University Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07070778
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 40 and 69 years old
  • People whose heart is pumping blood normally (a heart function measurement called ejection fraction must be above 50%)
  • People who do not have blocked or narrowed heart arteries, and do not have a serious heart valve problem
  • People who do not have fatty build-up in the arteries of the neck (carotid plaques)
  • People who are willing to take part in the research
  • People who are at least 15 months past their breast cancer surgery
  • People who are able to read, understand, and complete questionnaires and tests without difficulty
  • People who do less than 60 minutes of structured, planned exercise per week (considered physically inactive)

Who may not be able to join:

  • People who currently have an active infection
  • People who have had cancer in both breasts
  • People who have a history of surgery, nerve-related, or bone and joint problems (unrelated to breast cancer surgery) that affect how the arm and shoulder work
  • People who have a neurological condition or other diagnosed condition that may affect memory or thinking ability
  • People who had poor heart function, or serious liver or kidney problems before starting chemotherapy
  • People who have muscle or joint conditions, nerve conditions, heart symptoms, previous lung surgery, or another cancer that could affect their ability to exercise
  • People who have high blood pressure or diabetes that is not well controlled

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Melda Saglam, PhD, Hacettepe University

Phone: +903123051576

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
8 July 2025
Est. completion
1 November 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Arterial Stiffness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov